Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine (Episode 2)
read more
Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine
read more
Happy Nurses Week
HAPPY NURSES WEEK! The theme for National Nurses Week in 2020 is Compassion|Expertise|Trust. National Nurses Week is celebrated annually from May 6, also known as National Nurses Day, through May 12, the birthday of Florence Nightingale, the founder of modern nursing. This week is devoted to highlighting the diverse ways in which registered nurses work to improve health care. We have never been able to repay nurses for all the work they do. For how thankful we’ll always be, nothing can repay the sacrifices they make in...
read moreBlue Horizon Charitable Foundation is seeking funding to help fight COVID-19
What if stem cell treatments could help those with COVID-19? What if pneumonia brought on by the virus could be cured? That’s what we here at Blue Horizon are trying to find out. Our previous studies have shown that mesenchymal stem cells from the human umbilical cord have immunomodulatory, antimicrobial, anti-inflammatory and tissue repair functions, being a great potential for the prevention and treatment of viral diseases. Presently we are in the process of submission and obtaining an...
read moreChinese doctor claims he made a breakthrough in coronavirus pandemic with stem cell injections – having 100% success rate after treating nine mostly elderly patients
Click below to read the original...
read moreDr. Wu Summary On Coronavirus Study
Brief Summary: The 2019 novel coronavirus pneumonia first emerged in Wuhan, Hubei, China, in December 2019. The disease spread quickly to 26 countries worldwide representing a serious global public health threat. Common signs of infection include respiratory symptoms, fever, dry cough, shortness of breath and breathing difficulties. In more severe cases, the infection can cause pneumonia, severe acute respiratory system injury with overwhelming inflammation in the lung. To date, there are no anti-viral therapeutics that specifically target...
read moreBrian Mehling, MD participates in 9th Annual Brain Mapping Day
Brian Mehling, MD participated in the 9th Annual Brain Mapping Day: A joint Congressional briefing with the Society for Brain Mapping and Therapeutics, Brain Mapping Foundation, and the Congressional Neuroscience Caucus yesterday in Washington DC. The topic of Dr. Mehling’s presentation was “Safety and Efficacy of Stem Cell Therapy in Clinical Applications.” The materials presented focused on educating lawmakers about new technologies and innovations in the field of neuroscience, including stem cell therapy, enabling...
read moreBHI Therapeutic Sciences Jamaica celebrates one year anniversary
A little more than one year ago, BHI Therapeutic Sciences Jamaica (BHI Jamaica), located in Montego Bay opened its doors and welcomed its first stem cell therapy patients. Since then, more than 50 patients have been treated with advanced stem cell therapies. Brian Mehling, MD said: “Cellular medicine is in high demand and stem cells have the potential to treat a wide range of diseases. Stem cells are essentially “blank slate” cells that possess the remarkable potential to differentiate to any one of the billions of cells...
read moreBrian Mehling, MD, (R) and Dongecheng Wu, MD, Ph.D., (L) during the stem cell applications at BHI Jamaica.
Dr. Mehling is the founder and chief medical officer of Mehling Orthopedics and BHI Therapeutic Sciences (BHITS). He is a practicing American orthopedic trauma surgeon, researcher, and philanthropist. He is also spearheading groundbreaking research in stem cell therapy. Notably, BHITS is currently engaged in an FDA Investigational New Drug trial for stroke, using human umbilical cord blood (hUCB) stem cells. Completing his degree of medicine at Wright State University School of Medicine, Dr. Mehling received post graduate education...
read moreStem Cells Quality Reports
BHI Therapeutic Sciences is pioneering ethical, effective, safe and affordable stem cell treatment therapies utilizing cord blood stem cells. Its stem cell products evaluated in clinical studies are collected in accordance with Good Tissue Practice to ensure safety. The studies have been conducted following approval by an Investigational Research Board and in accordance with Good Clinical Practice. Results show its cellular products are safe and effective in the improvement of symptoms related to chronic inflammation, spinal...
read more
